Mannan binding lectin-associated serine protease 1 is induced by hepatitis C virus infection and activates human hepatic stellate cells

Clinical and Experimental Immunology

Volumn 174, Issue 2, 2013, Pages 265-273

  Saeed, A ^a   Baloch, K ^a   Brown, R J P ^a,d   Wallis, R ^b   Chen, L ^a   Dexter, L ^a,e   Mcclure, C P ^a   Shakesheff, K ^a   Thomson, B J ^a,c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^e UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Fibrosis; Hepatitis C; Innate immune response; MASP 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MANNAN BINDING LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEASE 1; RECOMBINANT PROTEIN; SERINE PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; CELL ACTIVATION; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL MODEL; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CELL CULTURE; LIVER FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; UPREGULATION;

FIBROSIS; HEPATITIS C; INNATE IMMUNE RESPONSE; MASP-1;

ACTINS; CELL DIFFERENTIATION; CELLS, CULTURED; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; DISEASE PROGRESSION; HEPACIVIRUS; HEPATIC STELLATE CELLS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; RECOMBINANT PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

EID: 84885127879     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12174     Document Type: Article

References (36)

1. Henderson NC, Iredale JP. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond) 2007; 112:265-280.
2. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134:1655-1669.
3. Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 2007; 22 (Suppl. 1):P73-78.
4. Thomson BJ. Hepatitis C virus: the growing challenge. Br Med Bull 2009; 89:153-167.
5. Brown KS, Keogh MJ, Tagiuri N etal. Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex. Clin Exp Immunol 2007; 147:90-98.
6. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectins, ficolins, and associated proteins. Mol Immunol 2007; 44:3875-3888.
7. Gal P, Harmat V, Kocsis A etal. A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations. J Biol Chem 2005; 280:33435-33444.
8. Heja D, Kocsis A, Dobo J etal. Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci USA 2012; 109:10498-10503.
9. Heja D, Harmat V, Fodor K etal. Monospecific inhibitors show that both mannan-binding lectin-associated serine protease-1 (MASP-1) and -2 are essential for lectin pathway activation and reveal structural plasticity of MASP-2. J Biol Chem 2012; 287:20290-20300.
10. Degn SE, Jensen L, Hansen AG etal. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J Immunol 2012; 189:3957-3969.
11. Megyeri M, Harmat V, Major B etal. Quantitative characterisation of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway. J Biol Chem 2013; 288:8922-8934.
12. Gulla KC, Gupta K, Krarup A etal. Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology 2010; 129:482-495.
13. Hess K, Ajjan R, Phoenix F etal. Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation. PLoS 2012; 7:e35690. doi: 10.1371/journal.pone.0035690.
14. Marra F, DeFranco R, Grappone C etal. Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. Hepatology 1998; 27:462-471.
15. Calvaruso V, Maimone S, Gatt A etal. Coagulation and fibrosis in chronic liver disease. Gut 2008; 57:1722-1727.
16. Gaca MD, Zhou X, Issa R etal. Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol 2003; 22:229-239.
17. Chen CB, Wallis R. Stoichiometry of complexes between mannose-binding protein and its associated serine proteases. Defining functional units of complement activation. J Biol Chem 2001; 276:25894-25902.
18. Wakita T, Pietschmann T, Kato T etal. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11:791-796.
19. Lindenbach BD, Evans MJ, Syder AJ etal. Complete replication of hepatitis C virus in cell culture. Science 2005; 309:623-626.
20. Terai I, Kobayashi K, Matsushita M, Fujita T. Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum. Clin Exp Immunol 1997; 110:317-323.
21. Mallat A, Gallois C, Tao J etal. Platelet-derived growth factor-BB and thrombin generate positive and negative signals from human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors. J Biol Chem 1998; 273:27300-27305.
22. Marra F, Grandaliano G, Valente AJ etal. Thrombin stimulates proliferation of liver fat storing cells and expression of monocyte-chemotactic protein-1: potential role in liver injury. Hepatology 1995; 22:780-787.
23. Megyeri M, Mako V, Beinrohr L etal. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function. J Immunol 2009; 183:3409-3416.
24. Schlapbach LJ, Mattmann M, Thiel S etal. Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis 2010; 15:153-162.
25. Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infect Immun 2012; 80:3343-3359.
26. Ali YM, Lynch NJ, Haleem KS etal. The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. PLoS Pathog 2012; 8:e1002793.
27. Zhang S, Kodys K, Babcock GJ, Szabo G. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of HCV-infected cells and induction of IFNα. Hepatology 2012. doi: 10.1002/hep.25827.
28. Zhang S, Kodys K, Li K, Szabo G. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection. Gastroenterology 2013; 144:414-425.
29. Tarr AW, Urbanowicz RA, Ball JK. The role of humoral innate immunity in hepatitis C virus infection. Viruses 2012; 4:1-27.
30. Iacob RE, Perdivara I, Przybylski M etal. Mass spectrometric characterization of glycosylation of hepatitis C virus E2 envelope glycoprotein reveals extended microheterogeneity of N-glycans. J Am Soc Mass Spectrom 2008; 19:428-444.
31. Liu J, Ali MA, Shi Y etal. Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell Mol Immunol 2009; 6:235-244.
32. Brown K, Keogh MJ, Owsianka AM etal. Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry. Protein Cell 2010; 1:664-674.
33. Blackham S, Baillie A, Al-Hababi F etal. Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus. J Virol 2010; 84:5404-5414.
34. Tulio S, Faucz FR, Werneck RI etal. MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection. Hum Immunol 2011; 72:912-915.
35. Eurich D, Boas-Knoop S, Morawietz L etal. Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma. Liver Int 2011; 31:1006-1012.
36. Dobo J, Harmat V, Beinrohr L, Sebestyen E, Zavodsky P, Gal P. MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity. J Immunol 2009; 183:1207-1214.